Should sodium glucose co ‐transporter 2 inhibitors be considered as first line oral therapy for people with type 2 diabetes?

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Kamlesh Khunti , Samuel Seidu , Melanie J Davies Source Type: research